Dozens of People Fall Sick in 28 States After ‘Microdosing’ Diamond Shruumz Edibles

• More than five dozen people have reported seeking medical attention after consuming Diamond Shruumz products.
• A study also found that some of the company’s gummies contained psilocin, a controlled substance.
• The FDA has reported 36 hospitalizations and one potential death associated with the products.

Diamond Shruumz, the company whose microdosed candy bars sparked an FDA investigation in June, also sold gummies made with an illegal substance, according to a new CDC report.

The FDA first alerted the general public about Diamond Shruumz products after eight people in four states became ill after consuming the retailer’s microdosed candy bars.

The FDA now says that as of July 15, those numbers have climbed to 69 illnesses in 28 states.

“Sixty (60) of the 69 individuals reported seeking medical attention, 36 were hospitalized, and one potentially associated death is under investigation,” the FDA said.

Microdosing is the practice of taking small doses of a drug, usually psychedelics like psilocybin, to enhance creativity and mental health. Microdosing has become a trend in Silicon Valley, even among CEOs.

Diamond Shruumz’s website states that its products do not contain psilocybin or any other listed drugs.

However, tests conducted by the University of Virginia Toxicology Lab found psilocin in Diamond Shruumz Sour Peach Apple and Rainbow candies.

Psilocin is a “psychedelic mushroom alkaloid,” according to the Metabolomics Innovation Center. The DEA considers psilocin a Schedule I controlled substance in some states, including Virginia, where the study was conducted.

The CDC study reported that five people underwent hospital evaluations between September 2023 and June 2024 after eating gummies labeled as containing Amanita muscaria.

Although Amanita muscaria can sometimes cause adverse symptoms, the report states that it is legal.

“Individuals who purchase products advertised as psychedelic or nootropic mushroom gummies should be aware that package labels may not accurately represent the contents and that these products may contain substances that may produce unexpected and potentially toxic effects,” the report said.

Representatives for Diamond Shruumz and the University of Virginia Toxicology Lab did not respond to a request for comment from Business Insider.

Diamond Shruumz recalled all of its products, including gummies and chocolate bars, in June after cases of illness continued to rise across the country.

The agency said it would monitor Prophet Premium Blends, the company behind Diamond Shruumz, during its recall.

“Consumers should not purchase or consume any Diamond Shruumz branded products,” the agency added.